Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000527135 | SCV000646299 | benign | Carney complex, type 1 | 2023-12-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000571388 | SCV000674447 | likely benign | Hereditary cancer-predisposing syndrome | 2017-07-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000571388 | SCV002534739 | benign | Hereditary cancer-predisposing syndrome | 2021-06-03 | criteria provided, single submitter | curation | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003114669 | SCV003800918 | benign | not specified | 2023-01-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003905412 | SCV004721662 | likely benign | PRKAR1A-related disorder | 2023-01-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |